Abstract
A large number of inhibitors of aldose reductase enzyme were submitted to the CASE (computer automated structure evaluation) program in order to ascertain the topological features relevant to activity. On the basis of the twenty-six biophores (activating fragments) and one biophobe (inactivating fragment), a new proposed interaction model was suggested for an aldose reductase enzyme with the chemical inhibitors. The critical relationship between enzyme inhibition and the structure of inhibitors is believed to depend on the relative positions of subordinate regions within the inhibitor structure.
Similar content being viewed by others
References
K. Lindsday, B.G. Buchanan, E.A. Feigenbaum and J. Lederberg,Application of Artificial Intelligence for Organic Chemistry: The DENDRAL Project (McGraw-Hill, New York, 1980).
R.O. Duda and E.H. Shortlife, Science 220 (1983) 261.
R. Osman, H. Weinstein, and J.P. Green, ACS Symp. Ser. 112 (1979) 21.
K. Yuta and P.C. Jurs, J. Med. Chem. 24 (1981) 241.
S. Dowe, K. Fronke, O.L. Monshjan, W.A. Schkuljev and L.W. Chashanjan, J. Med. Chem. 22 (1982) 521.
L.B. Kier, in:Molecular Orbital Theory, ed. L.B. Kier (Academic Press, New York, 1971).
G. Klopman, J. Amer. Chem. Soc., 106 (1984) 7315.
G. Klopman, M. MacGonigal, J. Chem. Inf. Comput. Sci. 106 21 (1981) 48.
G. Klopman, and R. Contreras, Mol. Pharmacol. 27 (1985) 86.
G. Klopman and A.N. Kalos, J. Theor. Biol. 118 (1986) 199.
G. Klopman, O.T. Macina, E.J. Simon and J.M. Miller, J. Mol. Struct. 134 (1986) 299.
G. Klopman and E. Buyukbingol, Mol. Pharmacol. 34 (1988) 852.
J.H. Kinoshita, D. Dvornik, M. Kraml and K.H. Gabbay, Biochim. Biophys. Acta 158 (1968) 472.
P.F. Kador and N.E. Sharpless, Biophys. Chem. 8 (1978) 81
S.D. Varma, I. Mikuni and J.H. Kinoshita, Science 188 (1975) 1215.
J. DeRuiter, A.N. Brubaker, W.L. Whitmer and J.L. Stein, Jr., J. Med. Chem. 29 (1986) 2024.
P.F. Kador, N.E. Sharpless and J.D. Goosey, Prog. Clin. Biol. Res. 114 (1982) 243.
J.R. Pfister and L.D. Goosey, Prog. Clin. Biol. Res. 114 (1982) 243.
J.R. Pfister and L.D. Waterbury, J. Med. Chem. 23 (1980) 1264.
K. Inagaki, I. Miwa, T. Yashiro and J. Okuda, Chem. Pharm. Bull. 30 (1982) 3244.
I. Miwa, M. Hirano, K. Inagaki, C. Belbeoch and J. Okuda, Biochem. Pharmacol. 36 (1987) 2789.
J.P. Rizzi, R.C. Schnur, N.J. Hutson, K.G. Kraus and P.R. Kelbaugh, J. Med. Chem. 32 (1989) 1208.
M.J. Peterson, R. Sarges, C.E. Aldinger and D.P. MacDonald, Metabolism 28, Suppl. 1 (1979) 456.
P.F. Kador, W.G. Robinson, Jr. and J.H. Kinoshita, Ann. Rev. Pharmacol. Toxicol. 25 (1985) 691.
J.H. Kinoshita, S. Fukushi, P.F. Kador and L.O. Merola Metabolism 28 (1979) 462.
P.F. Kador and N.E. Sharpless, Mol. Pharmacol. 24 (1983) 521.
P.F. Kador, J.H. Kinoshita and N.E. Sharpless, Metabolism 35 (1986) 109.
P.F. Kador, J.D. Goosey, N.E. Sharpless, J. Kolish and D.D. Miller, Eur. J. Med. Chem. 16 (1981) 293.
J.H. Kinoshita, P.F. Kador and M. Catiles, J. Amer. Med. Assoc. 246 (1981) 257.
K.H. Gabbay and J.B. O'Sullivan, Diabetes 17 (1986) 239.
J.H. Kinoshita, L.O. Merola, K. Satoh and E. Dikmak, Nature (London) 194 (1962) 1085.
P.F. Kador, J.H. Kinoshita and N.E. Sharpless, J. Med. Chem. 28 (1985) 841.
D. Dvornik Ann. Rep. Med. Chem. 13 (1978) 159.
P.R. Andrews, D.L. Craik and J.L. Martin, J. Med. Chem. 27 (1984) 1648.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Buyukbingol, E., Klopman, G. A new proposed model of aldose reductase enzyme inhibition on the basis of an artificial intelligence approach: A computer automated structure evaluation (case) study. J Math Chem 8, 195–205 (1991). https://doi.org/10.1007/BF01166936
Issue Date:
DOI: https://doi.org/10.1007/BF01166936